Ambient

Molecular Formula : C44H87NO3

Molecular Formula : C44H87NO3

Molecular Formula : C44H89NO3

Molecular Formula : C44H89NO3

Molecular Formula : C21H41NO3

Molecular Formula : C21H41NO3

Molecular Formula : C22 H43 N O3

Molecular Formula : C22 H43 N O3

Molecular Formula : C22 H43 N O3

Molecular Formula : C22 H45 N O3

Molecular Formula : C22 H45 N O3

Molecular Formula : C5H4ClN5

Molecular Formula : C24 H47 N O3

Molecular Formula : C24 H47 N O3

Molecular Formula : C24 H47 N O3

Molecular Formula : C2213C2H45D2NO3

Molecular Formula : C2213C2H45D2NO3

Molecular Formula : C26 H51 N O3

Molecular Formula : C26 H53 N O3

Molecular Formula : C26 H53 N O3

Molecular Formula : C26 H53 N O3

Molecular Formula : C30H40S2

Molecular Formula : C30H40S2

Molecular Formula : C30H40S2

Molecular Formula : C20H26BrNOS

Molecular Formula : C20H26BrNOS

Molecular Formula : No Data Available

Molecular Formula : C19H31N3O6

Molecular Formula : C19H31N3O6

CA125, known as cancer antigen 125, carcinoma antigen 125, and carbohydrate antigen 125, is a member of the mucin family glycoproteins. It is involved in boosting tumorigenesis and tumor proliferation and is considered as a useful biomarker for the diagnosis of ovarian cancer.

CA125, known as cancer antigen 125, carcinoma antigen 125, and carbohydrate antigen 125, is a member of the mucin family glycoproteins. It is involved in boosting tumorigenesis and tumor proliferation and is considered as a useful biomarker for the diagnosis of ovarian cancer.

CA125, known as cancer antigen 125, carcinoma antigen 125, and carbohydrate antigen 125, is a member of the mucin family glycoproteins. It is involved in boosting tumorigenesis and tumor proliferation and is considered as a useful biomarker for the diagnosis of ovarian cancer.

CA125, known as cancer antigen 125, carcinoma antigen 125, and carbohydrate antigen 125, is a member of the mucin family glycoproteins. It is involved in boosting tumorigenesis and tumor proliferation and is considered as a useful biomarker for the diagnosis of ovarian cancer.

CA125, known as cancer antigen 125, carcinoma antigen 125, and carbohydrate antigen 125, is a member of the mucin family glycoproteins. It is involved in boosting tumorigenesis and tumor proliferation and is considered as a useful biomarker for the diagnosis of ovarian cancer.

CA125, known as cancer antigen 125, carcinoma antigen 125, and carbohydrate antigen 125, is a member of the mucin family glycoproteins. It is involved in boosting tumorigenesis and tumor proliferation and is considered as a useful biomarker for the diagnosis of ovarian cancer.

MUC16, also known as the CA125 antigen, is a mucin protein that may be found in type I transmembrane or secreted forms that are used monitor the progress of epithelial ovarian cancer therapy. Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces. Binding to MSLN mediates heterotypic cell adhesion. This may contribute to the metastasis of ovarian cancer to the peritoneum by initiating cell attachment to the mesothelial epithelium via binding to MSLN.

CA15-3
(Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a
membrane-anchored, mucin-type glycoprotein present in malignant cells. It is
used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3
(Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a
membrane-anchored, mucin-type glycoprotein present in malignant cells. It is
used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3
(Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a
membrane-anchored, mucin-type glycoprotein present in malignant cells. It is
used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3
(Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a
membrane-anchored, mucin-type glycoprotein present in malignant cells. It is
used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3
(Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a
membrane-anchored, mucin-type glycoprotein present in malignant cells. It is
used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3
(Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a
membrane-anchored, mucin-type glycoprotein present in malignant cells. It is
used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3 (Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a membrane-anchored, mucin-type glycoprotein present in malignant cells. It is used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3 (Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a membrane-anchored, mucin-type glycoprotein present in malignant cells. It is used as tumor marker to monitor breast cancer treatment and disease recurrence.

CA15-3 (Carcinoma antigen 15-3) is also known as MUC 1 antigen. It is a membrane-anchored, mucin-type glycoprotein present in malignant cells. It is used as tumor marker to monitor breast cancer treatment and disease recurrence.

Carbohydrate
antigen 19-9 (CA19-9) is the sialylated form of Lewis Antigen. It may be
elevated in many types of gastrointestinal cancer, such as colorectal cancer,
esophageal cancer and hepatocellular carcinoma. It is useful for diagnosis and monitoring of
pancreatic cancer

Carbohydrate
antigen 19-9 (CA19-9) is the sialylated form of Lewis Antigen. It may be
elevated in many types of gastrointestinal cancer, such as colorectal cancer,
esophageal cancer and hepatocellular carcinoma. It is useful for diagnosis and monitoring of
pancreatic cancer

Carbohydrate
antigen 19-9 (CA19-9) is the sialylated form of Lewis Antigen. It may be
elevated in many types of gastrointestinal cancer, such as colorectal cancer,
esophageal cancer and hepatocellular carcinoma. It is useful for diagnosis and monitoring of
pancreatic cancer